Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis, 2015 Update

Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis, 2015 Update

Summary

Ortho-Clinical Diagnostics, Inc. (OCD) is a provider of vitro diagnostic products. The company designs, develops, manufactures and distributes in-vitro diagnostic products for the healthcare markets. OCD classifies its products into two categories: clinical laboratories and transfusion medicine. It serves clinical laboratories by providing total solutions for screening, diagnosing, monitoring and confirming diseases early. It also serves global transfusion medicine community by offering donor screening and blood typing products. The company's services includes e-connectivity, customer service and support, technical support, field engineer service, predictive technologies center, Ortho Plus SM services, product training and consulting services. The company has manufacturing facilities in Rochester New York, Pompano Beach, Florida and Wales. The company offers its products and services in North America, Latin America, Europe and Asia Pacific. Ortho-Clinical is headquartered in Raritan, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ortho-Clinical Diagnostics Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Ortho-Clinical Diagnostics Inc. Company Snapshot 6
Ortho-Clinical Diagnostics Inc. Company Overview 6
Key Information 6
Ortho-Clinical Diagnostics Inc. Pipeline Products and Clinical Trials Overview 7
Ortho-Clinical Diagnostics Inc. - Pipeline Analysis Overview 9
Business Description 9
Key Facts 10
Ortho-Clinical Diagnostics Inc. - Major Products and Services 11
Ortho-Clinical Diagnostics Inc. Pipeline Products by Development Stage 13
Ortho-Clinical Diagnostics Inc. Pipeline Products Overview 15
Next Generation VITROS System 15
Next Generation VITROS System Product Overview 15
ORTHO AutoVue - Rare Sera Assay 16
ORTHO AutoVue - Rare Sera Assay Product Overview 16
ORTHO BioVue - Rare Sera Assay 17
ORTHO BioVue - Rare Sera Assay Product Overview 17
OrthoVision Max 18
OrthoVision Max Product Overview 18
ProMu 19
ProMu Product Overview 19
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay 20
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay Product Overview 20
VITROS 5600 - High Sensitivity Troponin Assay 21
VITROS 5600 - High Sensitivity Troponin Assay Product Overview 21
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay 22
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay Product Overview 22
VITROS ECiQ - Free b-hCG assay 23
VITROS ECiQ - Free b-hCG assay Product Overview 23
VITROS EciQ - HIV Ag/Ab Combo Assay 24
VITROS EciQ - HIV Ag/Ab Combo Assay Product Overview 24
Ortho-Clinical Diagnostics Inc. - Key Competitors 25
Ortho-Clinical Diagnostics Inc. - Key Employees 26
Ortho-Clinical Diagnostics Inc. - Key Employee Biographies 27
Ortho-Clinical Diagnostics Inc. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Ortho-Clinical Diagnostics Inc., Recent Developments 30
Jun 18, 2015: Ortho-Clinical Diagnostics Receives FDA 510k Clearance for VITROS Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay 30
Apr 27, 2015: Ortho-Clinical Diagnostics Receives Health Canada Approval for ORTHO VISION Analyzer 31
Apr 27, 2015: Avioq Expands FDA and CE-IVD Claims for Testing Organ and Tissue Donors with the Avioq HTLV-I/II Microelisa System 31
Oct 28, 2014: Ortho-Clinical Diagnostics Receives CE Mark for ORTHO VISION Analyzer to Take Full Automation Transfusion Medicine Testing to Next Level 32
Oct 17, 2014: Ortho-Clinical Diagnostics Receives CE Mark for VITROS Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay 32
Jul 08, 2014: Ortho-Clinical Diagnostics Announces Executive Leadership Additions as It Becomes an Independent, Stand-Alone Company 33
Jun 16, 2014: Robert Yates to be Named Chief Operating Officer of Ortho-Clinical Diagnostics 33
Aug 13, 2013: Avioq Announces Health Canada Approval and Canadian Launch of HTLV-I/II Test 34
Apr 10, 2013: Avioq Announces CE Mark And European Launch Of HTLV-I/II Test 34
Dec 19, 2012: Hospitals, Healthcare Providers To Benefit From New Multi-Source Premier Agreements For Blood Bank Analyzers, Reagents, Consumables And Service 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Ortho-Clinical Diagnostics Inc., Key Facts 6
Ortho-Clinical Diagnostics Inc. Pipeline Products and Clinical Trials Overview 7
Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 7
Ortho-Clinical Diagnostics Inc. Pipeline Products by Indication 8
Ortho-Clinical Diagnostics Inc., Key Facts 10
Ortho-Clinical Diagnostics Inc., Major Products and Services 11
Ortho-Clinical Diagnostics Inc. Number of Pipeline Products by Development Stage 13
Ortho-Clinical Diagnostics Inc. Pipeline Products Summary by Development Stage 14
Next Generation VITROS System - Product Status 15
Next Generation VITROS System - Product Description 15
ORTHO AutoVue - Rare Sera Assay - Product Status 16
ORTHO AutoVue - Rare Sera Assay - Product Description 16
ORTHO BioVue - Rare Sera Assay - Product Status 17
ORTHO BioVue - Rare Sera Assay - Product Description 17
OrthoVision Max - Product Status 18
OrthoVision Max - Product Description 18
ProMu - Product Status 19
ProMu - Product Description 19
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay - Product Status 20
VITROS 3600 - HIV-1/2/O Ag/Ab Combo Assay - Product Description 20
VITROS 5600 - High Sensitivity Troponin Assay - Product Status 21
VITROS 5600 - High Sensitivity Troponin Assay - Product Description 21
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay - Product Status 22
VITROS 5600 - HIV-1/2/O Ag/Ab Combo Assay - Product Description 22
VITROS ECiQ - Free b-hCG assay - Product Status 23
VITROS ECiQ - Free b-hCG assay - Product Description 23
VITROS EciQ - HIV Ag/Ab Combo Assay - Product Status 24
VITROS EciQ - HIV Ag/Ab Combo Assay - Product Description 24
Ortho-Clinical Diagnostics Inc., Key Employees 26
Ortho-Clinical Diagnostics Inc., Key Employee Biographies 27
Ortho-Clinical Diagnostics Inc., Other Locations 28
Ortho-Clinical Diagnostics Inc., Subsidiaries 29

List of Figures
Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 8
Ortho-Clinical Diagnostics Inc. Pipeline Products by Development Stage 13